ARGX (argenx SE) EV-to-FCF: (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ARGX argenx SE ARGX
78 GF Score
Price $858.31
GF Value $1,429.25
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is argenx SE EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, argenx SE's Enterprise Value is $48,355 Mil. argenx SE's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil. Therefore, argenx SE's EV-to-FCF for today is .

The historical rank and industry rank for argenx SE's EV-to-FCF or its related term are showing as below:

ARGX' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 88.57
Current: 84.31

During the past 13 years, the highest EV-to-FCF of argenx SE was 88.57. The lowest was 0.00. And the median was 0.00.

ARGX's EV-to-FCF is ranked worse than
87.16% of 335 companies
in the Biotechnology industry
Industry Median: 15.34 vs ARGX: 84.31

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-14), argenx SE's stock price is $858.31. argenx SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $22.500. Therefore, argenx SE's PE Ratio (TTM) for today is 38.15.

argenx SE  (NAS:ARGX) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

argenx SE's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=858.31/22.500
=38.15

argenx SE's share price for today is $858.31.
argenx SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $22.500.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

argenx SE EV-to-FCF Related Terms

argenx SE EV-to-FCF Historical Data

* Premium members only.

The historical data trend for argenx SE's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

argenx SE EV-to-FCF Chart

argenx SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.08 -18.89 -40.97 -230.62 82.91

argenx SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 82.91 0.00

ARGX vs VRTX, REGN, ALNY: EV-to-FCF Comparison

For the Biotechnology subindustry, argenx SE's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

argenx SE EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where argenx SE's EV-to-FCF falls into.


ARGX
78GF Score
argenx SE ARGX
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

argenx SE EV-to-FCF Calculation

argenx SE's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=48354.530/0
=

argenx SE's current Enterprise Value is $48,355 Mil.
argenx SE's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is argenx SE (ARGX) Overvalued in 2026?

Based on GuruFocus' analysis, argenx SE stock appears to be undervalued. The current stock price of $858.31 is trading 39.9% below its estimated GF Value™ of $1,429.25. GuruFocus considers argenx SE to be Significantly Undervalued.

Key valuation signals for ARGX:

  • EV-to-FCF:
  • GF Value™: $1,429.25 vs. price of $858.31 (39.9% below fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the ARGX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

argenx SE Business Description

Address Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases. The company's lead product, Vyvgart (efgartigimod), was approved by the FDA in December 2021 for the treatment of generalized myasthenia gravis (gMG). In 2022, Argenx also received FDA approval for Vyvgart Hytrulo, a subcutaneous formulation of Vyvgart, offering a more convenient option compared with Vyvgart's intravenous administration. In 2024, the FDA approved Vyvgart Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy, a rare immune-mediated neuromuscular disorder of the peripheral nervous system. Argenx is focused on innovation and developing its pipeline for treatments such as primary immune thrombocytopenia, thyroid eye disease, and Sjogren's Disease.
78GF Score

Get the complete analysis for ARGX

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$858.31
Price
$1,429.25
GF Value